Cell and Gene Therapy CMO and CDMO Facilities

List of 74 Cell and Gene Therapy CMOs / CDMOs through 1 August 2018.

Global database of facilities that provide (mostly or exclusively) services as contract manufacturing organizations (CMO) and/or contract development and manufacturing organizations (CDMO) for the cell and gene therapy industry worldwide. As of 1 August 2018 the dataset contains 74 facilities providing CMO/CDMO services, including 55 companies and 19 academic or government facilities.

Included: Manufacturers of therapeutic cell products (unmodified or gene-modified), iPS cell lines for therapeutic products, viral vectors and DNA plasmids for cell and gene therapy industry.

Excluded: Contract research organizations (CROs) not performing manufacture of the therapeutic product, vendors of supplies (reagents, devices, etc.) 

For each company:

  • Facility name
  • Link to facility website if available
  • Country of origin
  • CMO/CDMO service expertise
  • File has separate lists for CMO/CDMO that are Industry versus Academic/ Government facilities.

 

Public samples:
AttachmentSize
Sample-CMO-facilities.xlsx10.51 KB